Developer docs
API playgroundTry for free, no card

Search company profiles

Brainstim Health

Full company profile

uuid00sv73i

Namestring
Brainstim Health
Legal namestring
BrainStim Health
Websiteurl
brainstim.ca
Company typeenum
Private
Founded yearint
2017
Descriptiontext

BrainStim Health is a Canadian private interventional psychiatry operator founded in 2017 and headquartered in Vancouver, British Columbia. The company runs a network of seven clinics across Canada (Vancouver, South Surrey, Halifax, Kingston, Ottawa, Calgary, and Perth) with a publicly stated plan to expand to ten clinics during 2026 (adding Edmonton, Markham, and Victoria). Its clinical offering centers on two modalities: Deep Transcranial Magnetic Stimulation (Deep TMS) using BrainsWay H-coil technology, and ketamine-assisted psychotherapy, supported by conventional psychotherapy (CBT and trauma-focused therapy). Indications addressed include treatment-resistant depression, PTSD, OCD, anxiety disorders, addiction, chronic pain, ADHD, and trauma, with a stated emphasis on patients who have not responded to medication and standard psychotherapy.

The company's primary customer segments are veterans and first responders — served through a dedicated program, a referral partnership with Veterans Affairs Canada, and a co-developed rTMS research collaboration with the Legion Veterans Village Research Foundation — alongside treatment-resistant depression patients in the general population. Revenue is generated on a fee-for-service basis at approximately $7,000 per TMS course, with patient financing offered through a Medicard partnership and partial coverage available via VAC and extended health plans. According to company materials, BrainStim has treated more than 1,000 patients and reports response rates up to 70% for treatment-resistant depression and 50-60% symptom reduction. Distribution is direct-to-patient via clinics, supplemented by a free 15-minute virtual consultation funnel, online self-referral, and healthcare-provider referrals. BrainStim holds minority equity investment from BrainsWay Ltd. ($1 million closed in February 2026, with up to $1.5 million in milestone-based follow-on), and the company is privately held.

Short descriptiontext

BrainStim Health is a Canadian private interventional psychiatry clinic operator running seven sites across Canada, offering Deep TMS and ketamine-assisted psychotherapy to treatment-resistant patients, with a primary focus on veterans and first responders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mental health clinics, transcranial magnetic stimulation, ketamine assisted therapy, interventional psychiatry, treatment resistant depression
Industry2 codes
1Psychiatry & Medication Management Platforms
CodeHLALAEABPrimaryYes
2General Mental Health Therapy Platforms (Talk Therapy)
CodeHLALAEAAPrimaryNo
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Mental Health Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Treatment Services
TypeProfessional Services
Description

BrainStim generates revenue through providing Deep TMS treatments, ketamine-assisted psychotherapy, and other mental health services at their clinics across Canada. Services include initial psychiatric evaluations, treatment sessions, and ongoing maintenance care. Treatment cost approximately $7,000 per course.

brainstim.ca
2Ketamine Therapy Sessions
TypeProfessional Services
Description

Revenue from psychedelic therapy sessions administered via IV infusion, IM injection, or oral lozenges, typically 6 sessions over 3-6 weeks for depression treatment.

brainstim.ca
3Payment Plans
TypeProfessional Services
Description

Partnership with Medicard provides monthly payment plans allowing patients to spread treatment costs over time.

brainstim.ca
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Deep TMS Treatment Course
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Approximately $7,000 per treatment course (typically 30 sessions). Some insurance companies cover part of the cost.

brainstim.ca
2Monthly Payment Plans
ModelSubscriptionBilling cadenceMonthly
Notes

Medicard easy and affordable payment plans allow spreading treatment costs over manageable monthly payments.

brainstim.ca
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

BrainStim Health operates a network of mental health clinics across Canada delivering advanced neurostimulation and psychedelic-assisted treatments for treatment-resistant mental health conditions. The core clinical offerings are Deep Transcranial Magnetic Stimulation (Deep TMS) and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. Treatments are provided by psychiatrist-led multidisciplinary teams and target conditions including treatment-resistant depression, PTSD, OCD, anxiety, addiction, chronic pain, ADHD, and trauma.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 70% response rate for treatment-resistant depression
+3 more records
Product overview1 text field

BrainStim Health operates a network of mental health clinics across Canada offering advanced neurostimulation and psychedelic-assisted therapy treatments. The company's core offerings consist of Deep TMS (Deep Transcranial Magnetic Stimulation) — a non-invasive brain stimulation treatment — and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. These treatments are delivered through a network of 7 clinics across Canada (Vancouver, South Surrey, Halifax, Kingston, Ottawa, Calgary, and Perth), with a specialized Veterans & First Responders Program addressing trauma, PTSD, and related conditions. The treatment portfolio covers treatment-resistant depression, PTSD, OCD, anxiety disorders, addiction, chronic pain, ADHD, and trauma. BrainStim positions itself as an interventional psychiatry practice offering alternatives to traditional medication-based treatments.

Product and service1 record
1Deep TMS (Deep Transcranial Magnetic Stimulation)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Partnership to investigate a new brain stimulation program using repetitive transcranial magnetic stimulation (rTMS) for veterans in British Columbia struggling with PTSD and chronic pain. Recruitment is open for eligible veterans. BrainStim works with Veterans Affairs Canada and assists eligible veterans with navigating benefit coverage.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Medicard provides easy and affordable payment plans allowing patients to pay for treatments and procedures on a monthly basis, spreading costs over time with manageable payments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BrainStim works with Veterans Affairs Canada and assists eligible veterans with navigating their benefit coverage for mental health treatments including TMS therapy.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

BetterHelp is the largest online talk-therapy platform. While a delivery-model outlier versus BrainStim, it is a comparable adjacent incumbent in the mental-health services category where BrainStim also offers psychotherapy alongside its interventional offerings.

TypeBroad incumbent
Description

Neuronetics is the publicly-listed maker of the NeuroStar TMS system and the dominant US TMS device vendor. Comparable to BrainStim as a TMS ecosystem incumbent and through its affiliated clinical service programs, and as a competitive device alternative to BrainsWay's H-coil platform.

TypeDirect peer
Description

Field Trip Health was a Canadian-headquartered operator of psychedelic-assisted therapy clinics combining ketamine and integration psychotherapy. Closely comparable to BrainStim on geography (Canada), interventional psychiatry positioning, and combination of ketamine with psychotherapy.

TypeEmerging player
Description

Affiliated TMS clinical service programs in Australia focused on treatment-resistant depression and related disorders. Comparable as a specialist neuromodulation service operator and clinical-research venue for TMS in a non-US market.

TypeEmerging player
Description

Mindbloom is a US-based at-home ketamine therapy platform for depression, anxiety, and PTSD. Compares to BrainStim on the ketamine-for-treatment-resistant-depression value proposition and target patient population, though delivering via telehealth rather than in-clinic.

TypeDirect peer
Description

Greenbrook operates the largest US network of physician-supervised TMS treatment centers for depression, OCD, and related conditions. Directly comparable to BrainStim as a multi-site TMS clinic operator with a focus on treatment-resistant mental health.

TypeDirect peer
Description

KCLA is one of the longest-running independent ketamine therapy clinic operators in the US, treating depression, PTSD, anxiety, and chronic pain. Directly comparable to BrainStim's ketamine-assisted psychotherapy service line and treatment-resistant mental-health positioning.

TypeOthers
Description

Spring Health is a global mental health benefits and care-navigation platform used by employers and payers. Adjacent to BrainStim as a channel/payer that increasingly routes patients to specialty providers, and a potential strategic partner for referral volume.

9Apollo TMS International
TypeDirect peer
Description

Apollo TMS operates TMS treatment centers focused on mental health and chronic pain across multiple US markets. Comparable as a multi-clinic TMS specialty operator serving similar treatment-resistant patient cohorts.

TypeBroad incumbent
Description

BrainsWay is the publicly-listed manufacturer of Deep TMS H-coil devices and a current strategic minority investor in BrainStim. It is comparable both as the underlying technology vendor that enables BrainStim's core service and as a clinical-platform sponsor (with several TMS clinic minority investments).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brainstim Health

Mental Health Servicesbrainstim.ca

BrainStim Health is a Canadian private interventional psychiatry clinic operator running seven sites across Canada, offering Deep TMS and ketamine-assisted psychotherapy to treatment-resistant patients, with a primary focus on veterans and first responders.

What Brainstim Health does

BrainStim Health is a Canadian private interventional psychiatry operator founded in 2017 and headquartered in Vancouver, British Columbia. The company runs a network of seven clinics across Canada (Vancouver, South Surrey, Halifax, Kingston, Ottawa, Calgary, and Perth) with a publicly stated plan to expand to ten clinics during 2026 (adding Edmonton, Markham, and Victoria). Its clinical offering centers on two modalities: Deep Transcranial Magnetic Stimulation (Deep TMS) using BrainsWay H-coil technology, and ketamine-assisted psychotherapy, supported by conventional psychotherapy (CBT and trauma-focused therapy). Indications addressed include treatment-resistant depression, PTSD, OCD, anxiety disorders, addiction, chronic pain, ADHD, and trauma, with a stated emphasis on patients who have not responded to medication and standard psychotherapy.

The company's primary customer segments are veterans and first responders — served through a dedicated program, a referral partnership with Veterans Affairs Canada, and a co-developed rTMS research collaboration with the Legion Veterans Village Research Foundation — alongside treatment-resistant depression patients in the general population. Revenue is generated on a fee-for-service basis at approximately $7,000 per TMS course, with patient financing offered through a Medicard partnership and partial coverage available via VAC and extended health plans. According to company materials, BrainStim has treated more than 1,000 patients and reports response rates up to 70% for treatment-resistant depression and 50-60% symptom reduction. Distribution is direct-to-patient via clinics, supplemented by a free 15-minute virtual consultation funnel, online self-referral, and healthcare-provider referrals. BrainStim holds minority equity investment from BrainsWay Ltd. ($1 million closed in February 2026, with up to $1.5 million in milestone-based follow-on), and the company is privately held.

Brainstim Health firmographics

Firmographics
Name
Brainstim Health
Legal name
BrainStim Health
Website
https://brainstim.ca
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
BrainStim Health is a Canadian private interventional psychiatry clinic operator running seven sites across Canada, offering Deep TMS and ketamine-assisted psychotherapy to treatment-resistant patients, with a primary focus on veterans and first responders.
Ownership category
akta.pro rank

Brainstim Health industry classification

Industry
Product category
Mental Health Services
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro primary industry
Psychiatry & Medication Management Platforms (HLALAEAB)
akta.pro secondary industry
General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)

Keywords

  • Mental health clinics
  • Transcranial magnetic stimulation
  • Ketamine assisted therapy
  • Interventional psychiatry
  • Treatment resistant depression

Where Brainstim Health is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices7 records

Markets served

Brainstim Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Treatment Services: BrainStim generates revenue through providing Deep TMS treatments, ketamine-assisted psychotherapy, and other mental health services at their clinics across Canada. Services include initial psychiatric evaluations, treatment sessions, and ongoing maintenance care. Treatment cost approximately $7,000 per course.
  2. Ketamine Therapy Sessions: Revenue from psychedelic therapy sessions administered via IV infusion, IM injection, or oral lozenges, typically 6 sessions over 3-6 weeks for depression treatment.
  3. Payment Plans: Partnership with Medicard provides monthly payment plans allowing patients to spread treatment costs over time.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDeep TMS Treatment Course
SubscriptionMonthlyMonthly Payment Plans

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Brainstim Health product offering

Product offering

Core offering

BrainStim Health operates a network of mental health clinics across Canada delivering advanced neurostimulation and psychedelic-assisted treatments for treatment-resistant mental health conditions. The core clinical offerings are Deep Transcranial Magnetic Stimulation (Deep TMS) and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. Treatments are provided by psychiatrist-led multidisciplinary teams and target conditions including treatment-resistant depression, PTSD, OCD, anxiety, addiction, chronic pain, ADHD, and trauma.

Product overview

BrainStim Health operates a network of mental health clinics across Canada offering advanced neurostimulation and psychedelic-assisted therapy treatments. The company's core offerings consist of Deep TMS (Deep Transcranial Magnetic Stimulation) — a non-invasive brain stimulation treatment — and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. These treatments are delivered through a network of 7 clinics across Canada (Vancouver, South Surrey, Halifax, Kingston, Ottawa, Calgary, and Perth), with a specialized Veterans & First Responders Program addressing trauma, PTSD, and related conditions. The treatment portfolio covers treatment-resistant depression, PTSD, OCD, anxiety disorders, addiction, chronic pain, ADHD, and trauma. BrainStim positions itself as an interventional psychiatry practice offering alternatives to traditional medication-based treatments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Deep TMS (Deep Transcranial Magnetic Stimulation)

Quantifiable outcome

  • Up to 70% response rate for treatment-resistant depression
  • +3 more outcomes

Companies that use Brainstim Health

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles2 records

Brainstim Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Brainstim Health partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship, minor and core.

  • Legion Veterans Village Research FoundationflagshipStrategic or Co-development PartnerPartnership to investigate a new brain stimulation program using repetitive transcranial magnetic stimulation (rTMS) for veterans in British Columbia struggling with PTSD and chronic pain. Recruitment is open for eligible veterans. BrainStim works with Veterans Affairs Canada and assists eligible veterans with navigating benefit coverage.
  • MedicardminorChannel Partner/ Reseller/ DistributorMedicard provides easy and affordable payment plans allowing patients to pay for treatments and procedures on a monthly basis, spreading costs over time with manageable payments.
  • Veterans Affairs Canada (VAC)coreStrategic or Co-development PartnerBrainStim works with Veterans Affairs Canada and assists eligible veterans with navigating their benefit coverage for mental health treatments including TMS therapy.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Brainstim Health competitors and assessment

Company assessment

Broad incumbents

  • BetterHelp: BetterHelp is the largest online talk-therapy platform. While a delivery-model outlier versus BrainStim, it is a comparable adjacent incumbent in the mental-health services category where BrainStim also offers psychotherapy alongside its interventional offerings.
  • Neuronetics: Neuronetics is the publicly-listed maker of the NeuroStar TMS system and the dominant US TMS device vendor. Comparable to BrainStim as a TMS ecosystem incumbent and through its affiliated clinical service programs, and as a competitive device alternative to BrainsWay's H-coil platform.
  • BrainsWay Ltd. BrainsWay is the publicly-listed manufacturer of Deep TMS H-coil devices and a current strategic minority investor in BrainStim. It is comparable both as the underlying technology vendor that enables BrainStim's core service and as a clinical-platform sponsor (with several TMS clinic minority investments).

Direct peers

  • Field Trip Health: Field Trip Health was a Canadian-headquartered operator of psychedelic-assisted therapy clinics combining ketamine and integration psychotherapy. Closely comparable to BrainStim on geography (Canada), interventional psychiatry positioning, and combination of ketamine with psychotherapy.
  • Greenbrook TMS NeuroHealth Centers: Greenbrook operates the largest US network of physician-supervised TMS treatment centers for depression, OCD, and related conditions. Directly comparable to BrainStim as a multi-site TMS clinic operator with a focus on treatment-resistant mental health.
  • Ketamine Clinics of LA (KCLA): KCLA is one of the longest-running independent ketamine therapy clinic operators in the US, treating depression, PTSD, anxiety, and chronic pain. Directly comparable to BrainStim's ketamine-assisted psychotherapy service line and treatment-resistant mental-health positioning.
  • Apollo TMS International: Apollo TMS operates TMS treatment centers focused on mental health and chronic pain across multiple US markets. Comparable as a multi-clinic TMS specialty operator serving similar treatment-resistant patient cohorts.

Emerging players

  • Black Dog Institute / Black Dog TMS: Affiliated TMS clinical service programs in Australia focused on treatment-resistant depression and related disorders. Comparable as a specialist neuromodulation service operator and clinical-research venue for TMS in a non-US market.
  • Mindbloom: Mindbloom is a US-based at-home ketamine therapy platform for depression, anxiety, and PTSD. Compares to BrainStim on the ketamine-for-treatment-resistant-depression value proposition and target patient population, though delivering via telehealth rather than in-clinic.

Others

  • Spring Health: Spring Health is a global mental health benefits and care-navigation platform used by employers and payers. Adjacent to BrainStim as a channel/payer that increasingly routes patients to specialty providers, and a potential strategic partner for referral volume.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Brainstim Health social profiles

Digital presence

Brainstim Health compliance and trust

Trust signal

Compliance4 records

Brainstim Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brainstim Health leadership team

Management profile

Number of profiles

Profiles7 records

Brainstim Health funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brainstim Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brainstim Health

What does Brainstim Health do?

BrainStim Health operates a network of mental health clinics across Canada delivering advanced neurostimulation and psychedelic-assisted treatments for treatment-resistant mental health conditions. The core clinical offerings are Deep Transcranial Magnetic Stimulation (Deep TMS) and Ketamine-Assisted Psychotherapy, supported by traditional psychotherapy services. Treatments are provided by psychiatrist-led multidisciplinary teams and target conditions including treatment-resistant depression, PTSD, OCD, anxiety, addiction, chronic pain, ADHD, and trauma.

Is Brainstim Health a public or private company?

Brainstim Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Brainstim Health founded?

Brainstim Health was founded in 2017. It employs 1 to 10 people.

Where is Brainstim Health based?

Brainstim Health is headquartered in Vancouver, Canada, in the North America region.

How does Brainstim Health make money?

Three revenue lines are on record. Clinical Treatment Services are the primary driver. The others are ketamine Therapy Sessions and payment Plans.

Who are Brainstim Health's main competitors?

Broad incumbents on record are BetterHelp, Neuronetics and BrainsWay Ltd.. Direct peers are Field Trip Health, Greenbrook TMS NeuroHealth Centers, Ketamine Clinics of LA (KCLA) and Apollo TMS International. Emerging players are Black Dog Institute / Black Dog TMS and Mindbloom. Spring Health is listed as an others.

Does Brainstim Health have an API?

No public API is recorded for Brainstim Health.

What industry is Brainstim Health in?

Brainstim Health's product category is Mental Health Services. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms, with a secondary code of HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy). Its NAICS code is 621112 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanBrainsWay invests $1M in Canada's BrainStim HealthBrainsWay Ltd., a global leader in noninvasive neurostimulation treatments, has made a $1 million minority-stake investment in Canadian mental health provider BrainStim Health Inc., with potential for an additional $1.5 million through milestone-based investments. The investment represents BrainsWay's fifth minority-stake investment in growth-oriented clinical service platforms as part of its strategy to expand access to and awareness of its Deep TMS technology across North America.GlobeNewswireBrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.BrainsWay Ltd., a global leader in Deep TMS neurostimulation treatments, announced a strategic equity financing agreement to invest $1.0 million initially (with potential for an additional $1.5 million in milestone-based payments) for a minority stake in BrainStim Health Inc., a British Columbia-based mental health provider serving clinics across Canada. This represents BrainsWay's fifth minority-stake investment into clinical service platforms as part of its strategy to expand access to and awareness of its Deep TMS technology while continuing to focus on its core scientific and clinical advancement. BrainStim, which specializes in treating conditions including severe trauma, stress, anxiety, and depression with a focus on veterans and first responders, views the partnership as strengthening its value proposition and enabling organizational growth.BrainswayBrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.BrainsWay Ltd., a global leader in noninvasive neurostimulation treatments, announced a strategic equity financing agreement with Canadian mental health provider BrainStim Health Inc., investing $1.0 million initially with potential for an additional $1.5 million via milestone-based investments for a minority equity position. The investment takes the form of a preferred, annually compounding security with a redemption mechanism and represents BrainsWay's fifth minority-stake investment into growth-oriented clinical service platforms. The partnership aims to expand access to Deep TMS technology and accelerate BrainStim's growth as an interventional psychiatry practice serving veterans and first responders.TipranksBrainsway announces new minority-stake investment in BrainStim HealthBrainsWay announced a strategic equity financing agreement to invest an initial $1.0 million in BrainStim Health, a British Columbia-based provider servicing mental health clinics in Canada, with potential for an additional $1.5 million through milestone-based investments. The investment gives BrainsWay a minority position in BrainStim in the form of a preferred, annually compounding security with a redemption mechanism. This marks BrainsWay's fifth minority-stake investment into clinical service platforms as part of its strategy to expand access to Deep TMS technology while focusing on scientific advancement.Investing.comBrainsWay invests $1 million in Canadian mental health provider BrainStim By Investing.comBrainsWay Ltd. has invested $1 million in BrainStim Health Inc., a Canadian mental health provider based in British Columbia, with potential for an additional $1.5 million through milestone-based investments, giving BrainsWay a minority stake in the company. This marks BrainsWay's fifth minority-stake investment in clinical service platforms, aligning with its strategy to expand its Deep TMS technology reach. BrainStim focuses on interventional psychiatry treating veterans and first responders with conditions including trauma, stress, anxiety, and depression.